PHARMACEUTICAL COMPOSITION FOR ANTI-INFLAMMATION, OR PROMOTION OF BONE TISSUE FORMATION OR CARTILAGE TISSUE FORMATION, WHICH CONTAINS STAUNTONIA HEXAPHYLLA LEAF-DERIVED EXTRACT OR FRACTIONAL PURIFIED PRODUCT OR NOVEL FLAVONOID COMPOUND AND CAFFEIC ACID COMPOUND SEPARATED THEREFROM AS ACTIVE COMPONENTS

摘要

The present invention relates to: a manufacturing method of a Stauntonia hexaphylla leaf-derived extract or a fractional purified product; the Stauntonia hexaphylla leaf-derived extract or the fractional purified product manufactured by the manufacturing method; and a pharmaceutical composition for anti-inflammation, or promotion of bone tissue formation or cartilage tissue formation, which contains at least one selected from a group consisting of the Stauntonia hexaphylla leaf-derived extract, the fractional purified product, or a caffeic acid compound and a novel flavonoid compound separated from the extract or the fractional purified product as active components.;COPYRIGHT KIPO 2020